D Design

Trademark usage description

pharmaceutical preparations for the treatment of central nervous system [cns] diseases and mental health disorders; pharmaceutical products for the tr Read More

Vienna Information

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 21

One letterUne lettre

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases and mental health disorders; pharmaceutical products for the treatment of central nervous system [CNS] diseases and mental health disorders; pharmaceutical preparations for the treatment of mental health disorders; pharmaceutical drugs for the treatment of mental health disorders; psychedelic pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; psychedelic-based medicines pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; neurogenerative drugs pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; serotonin receptor agonists and antagonist drugs pharmaceuticals for the treatment of central nervous system [CNS] diseases and mental health disorders; abuse deterrent products; pharmaceutical preparations for managing a mental, a behavioural, or a neuropsychiatric condition, or its symptoms, namely motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, behaviour; pharmaceutical preparations for use in psychedelic therapies for the treatment of mental health disorders

Classification kind code

Class [009]
Downloadable applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; computer software applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical alert response systems for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical alert response systems for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a medical device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a medical device (SaMD) for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a medical device (SaMD) for stimulating nerves

Classification kind code

Class [010]
Electroencephalogram (EEG) devices, namely electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of pharmaceuticals; medical devices for monitoring, sensing, measuring and training brain and neural activity; medical devices for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical device used in combination with pharmaceutical preparations for treating mental health disorders non-invasively namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity

Classification kind code

Class [035]
Operation of a pharmaceutical business, namely, wholesale distribution and sale of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; commercialization of pharmaceuticals, drugs, therapies and health care products namely, selling, sample distribution for others, developing of marketing strategies for others in the field of pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; operation of a pharmaceutical business, namely, wholesale distribution and sale of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders; commercialization of pharmaceuticals, drugs, and health care products namely, selling, sample distribution for others, developing of marketing strategies for others in the field of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders

Classification kind code

Class [040]
Custom manufacture of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders

Classification kind code

Class [042]
Pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical research and development in the field of mental health treatments; drug discovery; consultancy pertaining to pharmacology; psychedelic pharmaceutical drug research and psychedelic pharmaceutical drug development in the field of mental health conditions, illnesses and disorders; research in the field of mental health conditions, illnesses and disorders; neuropsychiatric drug discovery including pre-clinical and clinical drug development; pharmaceutical drug development services and discovery including new chemical entities, neurogenerative drugs, seretonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms

Classification kind code

Class [045]
Licensing of intellectual property in the field of pharmaceuticals, drugs, therapies and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, therapies and health care products used to treat mental conditions, illnesses and disorders

Classification kind code

Mark Details

Serial Number

2125710

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 19^th Mar 2025	Approval Notice Sent
Submitted for opposition 26 on 19^th Mar 2025	Approved
Submitted for opposition 67 on 27^th Sept 2024	Agent Name Changed
Submitted for opposition 22 on 11^th Jun 2024	Search Recorded
Submitted for opposition 20 on 11^th Jun 2024	Examiner's First Report
Submitted for opposition 287 on 27^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 287 on 26^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 6^th Aug 2021	Filed
Submitted for opposition 1 on 6^th Aug 2021	Created
Submitted for opposition 31 on 6^th Aug 2021	Formalized